THE ROLE OF PHARMACEUTICALS IN THE PREVENTION AND TREATMENT OF DISEASES OF THE FEMALE REPRODUCTIVE SYSTEM

528 Volume 5, Issue 10: Special Issue (EJAR) ISSN: 2181-2020 MPHAPP THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE “MODERN PHARMACEUTICS: ACTUAL PROBLEMS AND PROSPECTS” TASHKENT, OCTOBER 17, 2025 in-academy.uz THE ROLE OF PHARMACEUTICALS IN THE PREVENTION AND TREATMENT OF DISEASES OF THE FEMALE REPRODUCTIVE SYSTEM Ziyayeva Sh.T. Erkenova S.D. Tashkent State Medical University, Tashkent, Uzbekistan e-mail: [email protected] https://doi.org/10.5281/zenodo.17343993 Relevance: Modern pharmacological drugs play a key role in the prevention and treatment of diseases of the female reproductive system, such as menstrual cycle disorders, endometriosis, polycystic ovary syndrome (PCOS), infertility, and osteoporosis. The assessment of the effectiveness and safety of drugs aimed at hormonal therapy, the use of drugs to improve fertility, as well as drugs that regulate metabolism and immune reactions, is an important aspect of modern pharmacotherapy in gynecology. The purpose of the study is to evaluate the effectiveness and safety of pharmacological agents used for the prevention and treatment of diseases of the female reproductive system, with a focus on hormonal therapy, fertility-enhancing drugs, and agents that regulate metabolism and immune responses, in the context of their impact on women's health, improving their quality of life, and restoring their reproductive functions. Materials and methods: The study used works on the pharmacodynamics and pharmacokinetics of drugs, as well as clinical trials conducted with women suffering from reproductive diseases. The methodology includes: analysis of scientific publications data: a systematic review and meta-analysis of published data on the use of pharmacological agents in the treatment of diseases of the female reproductive system. For this, the databases PubMed, Google Scholar, Scopus and Cochrane Library were used. Pharmacokinetic modeling method: Analysis of the pharmacokinetic properties of drugs used to treat diseases of the female reproductive system to assess their dosage, half-life, and potential for accumulation in the body. Discussion results: The use of hormonal medications (such as oral contraceptives, progestins, and hormonal inhalers) in the treatment of female reproductive system disorders, such as endometriosis and amenorrhea, has shown significant improvement in patient conditions. These medications are effective in normalizing the menstrual cycle, reducing pain, and reducing the risk of complications such as infertility. However, their long-term use is associated with potential risks, such as an increased likelihood of venous thrombosis and hormonal imbalances, which require careful medical monitoring. Treatment of Polycystic Ovary Syndrome (PCOS): Medications for metabolic disorders, such as insulin sensitizers (metformin), are widely used in the treatment of PCOS. Their use helps restore normal insulin levels and improves ovulation. In combination with drugs that regulate hormonal balance, such as clomiphene citrate, metformin improves reproductive function and increases the likelihood of conception. However, the effectiveness of these drugs may vary depending on the severity of the syndrome and the presence of concomitant diseases. Fertility products: Drugs used to improve fertility (clomiphene, gonadotropins) have demonstrated high efficacy in the treatment of female infertility, especially in cases of ovulation problems. However, these medications do not always provide long-lasting results and may be accompanied by side effects such as ovarian hyperstimulation. The challenges in selecting the most appropriate treatment method, as well as the need for continuous monitoring of patient conditions, highlight the importance of an individualized approach. While pharmacological interventions are effective, they may also cause 529 Volume 5, Issue 10: Special Issue (EJAR) ISSN: 2181-2020 MPHAPP THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE “MODERN PHARMACEUTICS: ACTUAL PROBLEMS AND PROSPECTS” TASHKENT, OCTOBER 17, 2025 in-academy.uz undesirable side effects that must be considered when prescribing therapy. For example, hormone therapy can lead to undesirable changes in lipid metabolism, weight gain, and an increased risk of thrombosis. This requires an individualized approach to each patient and ongoing monitoring of their health, especially in women with a predisposition to cardiovascular diseases. Currently, there is an active effort to develop more specific and safe pharmacological treatments for reproductive system disorders. New drugs that target the molecular mechanisms of diseases promise to be more effective and minimize side effects. In the future, this could lead to the development of personalized treatment regimens for women suffering from reproductive disorders. Conclusions: The use of pharmacological agents in the treatment of diseases of the female reproductive system, such as polycystic ovary syndrome (PCOS), endometriosis, infertility, and menstrual cycle dysfunction, demonstrates high efficiency. Hormonal therapy, including oral contraceptives and progestins, is actively used to regulate hormonal levels, reduce pain, and normalize the menstrual cycle. Fertility-enhancing medications, such as clomiphene, gonadotropins, and insulin sensitizers, have shown positive results in the treatment of female infertility. These medications help restore ovulation and increase the chances of conception, particularly in women with PCOS. However, despite their effectiveness, many of these medications may have side effects, such as an increased risk of thrombosis with hormonal medications, as well as potential endocrine and metabolic disorders. This requires an individualized approach to therapy and regular monitoring of the patient's condition. The discussion highlights the need for a comprehensive approach to treating female reproductive system disorders, which includes not only pharmacotherapy but also lifestyle changes, dietary therapy, physical activity, and psychological support. This approach contributes to a higher quality of life for patients and increases the likelihood of successful treatment.